UPMC’s Comprehensive Pulmonary Hypertension (PH) Program
The University of Pittsburgh Medical Center (“UPMC”) is one of the leading nonprofit health systems in the United States. As Pennsylvania’s largest employer, with more than 55,000 employees, UPMC is comprised of more than 20 hospitals, more than 400 clinical locations, and a growing international and commercial segment.
A $10 billion integrated global health enterprise headquartered in Pittsburgh, Pennsylvania, UPMC develops and delivers “Life Changing Medicine” by harnessing the power of technology, translating science into cures, and accelerating the pace of innovation worldwide.
A passion for innovation lies at the heart of UPMC’s success. UPMC’s unique strategy of combining clinical and research excellence with business-like discipline translates into high-quality patient care for both western Pennsylvanians and the global community.
UPMC’s Comprehensive Pulmonary Hypertension (PH) Program is one of a few centers in the United States to offer highly specialized, comprehensive, state-of-the-art diagnosis and treatment of this complex disease.
Led by Michael Mathier, MD, the program includes a team of experts, such as cardiologists, pulmonologists, palliative care physicians, specialty nurses, nurse practitioners, physical therapists, and social workers.
It offers a full range of medical and surgical therapies for PH patients. Our experts are also pioneering studies to better treat persons with PH. The program works in partnership with UPMC’s world-class Lung Transplant Program, one of the most experienced in the nation.
For more about pulmonary hypertension and the Comprehensive Pulmonary Hypertension Center, view the informative video below (courtesy of UPMC Life Changing Medicine).